Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

INTRODUCTION: We assessed the efficacy and safety of repository corticotropin injection (RCI; Acthar(®) Gel) for persistently active systemic lupus erythematosus (SLE) despite use of moderate-dose glucocorticoids. METHODS: This multicenter, double-blind, randomized, placebo-controlled study enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Askanase, Anca D., Zhao, Enxu, Zhu, Julie, Bilyk, Roman, Furie, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695765/
https://www.ncbi.nlm.nih.gov/pubmed/32996096
http://dx.doi.org/10.1007/s40744-020-00236-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695765/
https://www.ncbi.nlm.nih.gov/pubmed/32996096
http://dx.doi.org/10.1007/s40744-020-00236-1

Ejemplares similares